The successful journey towards scaling up the use of health data
2 December 2025 | Ghent, Belgium
eSource-enabled Clinical Trials
Clinical trials are entering a new era—and health data collected as clinical care, is at the heart of the transformation. This session will bring together leading voices from hospitals, clinical study sites, technology providers and the pharmaceutical industry to explore how European institutions can scale up the reuse of Electronic Health Records (EHRs) as a powerful enabler of innovation as eSource in trial design and execution.
Join us as we uncover the next wave of strategies to harness real-world data for smarter, faster, and more inclusive trials.
You will learn:
How this shift is reshaping the market for technology vendors and processes within clinical study sites—and how you can ride this momentum
What resources are available to support you as part of this scale up, including the eSource Playbook: practical guidance for hospitals, tech developers and pharma to accelerate readiness
The essential EHR capabilities resulting from recent EU projects - EU PEARL and xShare requirements—including data quality, IPS (International Patient Summary), and IPS+ (extension of IPS for research), and robust governance frameworks
What the “game changers” are: key innovations and policy shifts that will shape the future of trial conduct
Why now is the time to invest in eSource—and how being part of this ecosystem will unlock new value for every stakeholder
If you are a clinical site looking to improve your research capabilities, a technology vendor seeking to lead with confidence, or a pharma team developing agile trial protocols—this session will give you the tools, insights, and connections to thrive in the evolving eSource landscape.
Let’s build the future of clinical research—where better data means better outcomes.
This first-ever eSource conference is a part of the Joining the Dots Week, a series of events surrounding i~HD's 10th Anniversary Annual Conference 2025.
Quick links for interested participants and sponsors